Sun Pharma drops over 5 percent; shares hit 52-week low Ruby Khatun Khatun11 Aug 2017 9:25 AM ISTNew Delhi: Shares of Sun Pharmaceutical Industries fell by over 5 per cent amid reports that its subsidiary Taro Pharmaceutical Industries reported...
Ministry of AYUSH develops drugs for Dengue, Cancer Ruby Khatun Khatun11 Aug 2017 9:18 AM ISTNew Delhi: The Ministry of Ayurveda, Unani, Siddha and Homeopathy (AYUSH) has developed drugs for Dengue, cancer, migrain and asthma, the Rajya Sabha...
Zydus Cadila gets USFDA nod to market hypertension drug Ruby Khatun Khatun11 Aug 2017 9:16 AM ISTNew Delhi: Drug firm Zydus Cadila has received the US health regulator's nod to market Diltiazem Hydrochloride capsules, used to treat high blood...
Lupin receives USFDA nod for cholesterol drug Ruby Khatun Khatun11 Aug 2017 9:15 AM ISTNew Delhi: Drug firm Lupin has received approval from the US health regulator to market Pitavastatin tablets used for lowering cholesterol.In a BSE...
FDA to expand public education campaign to focus on prevention of youth e-cigarette use Ruby Khatun Khatun11 Aug 2017 9:15 AM ISTThe U.S. Food and Drug Administration (FDA) announced it would pursue a strategic, new public health education campaign aimed at discouraging the use...
Roche unloads some rights to drug hopeful after asthma trial disappointment Ruby Khatun Khatun11 Aug 2017 9:14 AM ISTZURICH: Roche is offloading some rights to what was once one of its top drug prospects, lebrikizumab, for payments which could total more than $1...
Bristol-Myers Squibb to buy IFM Therapeutics to strengthen cancer pipeline Ruby Khatun Khatun11 Aug 2017 9:14 AM ISTBristol-Myers Squibb Co said it would buy privately held IFM Therapeutics for an upfront payment of $300 million, as the drugmaker looks to bolster...
Mylan Launches Avonza in India for HIV Ruby Khatun Khatun10 Aug 2017 10:00 AM ISTHERTFORDSHIRE, England and PITTSBURGH: Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V., a leading global pharmaceutical company, has...
FDA approves Mavyret for Hepatitis C Ruby Khatun Khatun10 Aug 2017 9:45 AM ISTThe U.S. Food and Drug Administration (FDA) approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV)...
Zydus Cadila gets USFDA nod to market HIV drug Ruby Khatun Khatun10 Aug 2017 9:30 AM ISTNew Delhi: Drug firm Zydus Cadila on Tuesday said it has received the tentative approval from the US health regulator to market Abacavir and...
The Ministry of AYUSH grants Rs 3.5 crore to conduct research in Ayurveda and other alternative medicines Ruby Khatun Khatun10 Aug 2017 9:20 AM ISTThe Interdisciplinary School of Health Sciences (ISHS) at Savitribai Phule Pune University, which offers post graduate courses in public health,...
Abbott India Q1 net profit down 35 percent at Rs 48 crore Ruby Khatun Khatun10 Aug 2017 9:16 AM ISTNew Delhi: Pharmaceuticals firm Abbott India on Tuesday reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended...
